Elevated activity of superoxide dismutase in male late-life schizophrenia and its correlation with clinical symptoms and cognitive deficits
Abstract Background Despite inconsistent findings, accumulative evidence has shown abnormalities of the key antioxidant enzyme, superoxide dismutase (SOD), in patients with schizophrenia. However, few studies explored SOD in late-life schizophrenia (LLS). Our work aimed to investigate changes in SOD...
Guardado en:
Autores principales: | Lijuan Huo, Xiaobing Lu, Fengchun Wu, Catherine Chang, Yuping Ning, Xiang Yang Zhang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f39b38a2199c41218b67b24944a6e6c2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Negative Symptoms of Schizophrenia: New Prospects of Cariprazine Treatment
por: Aleksandr M. Reznik, et al.
Publicado: (2020) -
Case Report: Cariprazine Efficacy in Young Patients Diagnosed With Schizophrenia With Predominantly Negative Symptoms
por: Octavian Vasiliu
Publicado: (2021) -
Online Left-Hemispheric In-Phase Frontoparietal Theta tACS for the Treatment of Negative Symptoms of Schizophrenia
por: Chuan-Chia Chang, et al.
Publicado: (2021) -
Cariprazine: Patients with Treatment-Resistant Schizophrenia
por: Aubel T
Publicado: (2021) -
Influence of CFH gene on symptom severity of schizophrenia
por: Zhang C, et al.
Publicado: (2017)